Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019-Reference-Cited by-同舟云学术

Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019

Published:2021-12-01 Issue:6 Volume:6 Page:559-563
ISSN:2578-5125
Container-title:Cannabis and Cannabinoid Research
language:en
Short-container-title:Cannabis and Cannabinoid Research

Author:

Wagoner Kimberly G.¹^ORCID,Lazard Allison J.²³^ORCID,Romero-Sandoval E. Alfonso⁴^ORCID,Reboussin Beth A.⁵

Affiliation:

1. Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

2. Hussman School of Journalism and Media, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

3. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

4. Department of Anesthesiology, Pain Mechanisms Laboratory, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

5. Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Complementary and alternative medicine,Pharmacology

Link

https://www.liebertpub.com/doi/pdf/10.1089/can.2020.0166

Reference24 articles.

1. 1. National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinioids: the current state of evidence recommendations for research. National Academies of Sciences, Engineering, and Medicine: Washington, DC, 2017.

2. Cannabidiol: State of the art and new challenges for therapeutic applications

3. New trends in cannabis potency in USA and Europe during the last decade (2008–2017)

4. Changes in Cannabis Potency Over the Last 2 Decades (1995–2014): Analysis of Current Data in the United States

5. Potency Trends of Δ9-THC and Other Cannabinoids in Confiscated Marijuana from 1980–1997

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Legal and Regulatory Aspects of Medical Cannabis in the United States;Anesthesia & Analgesia;2023-12-15

2. Thoughtfully Integrating Cannabis Products Into Chronic Pain Treatment;Anesthesia & Analgesia;2023-12-15

3. Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms;The Journal of Pain;2023-10

4. Medicinal Cannabis Use for Rheumatic Conditions in the US Versus Canada: Rationale for Use and Patient–Health Care Provider Interactions;ACR Open Rheumatology;2023-07-31

5. The analysis of cannabinoids in e-cigarette liquids using LC-HRAM-MS and LC-UV;Journal of Pharmaceutical and Biomedical Analysis;2023-06